Mallinckrodt Enterprises LLC

Hazelwood, MO ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
1,194ParticipantsFirst year on file
$2.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#21 of 46Manufacturing in MOBy participants

Overview

Mallinckrodt Enterprises LLC sponsors a self-funded health plan that covered 1,194 participants in plan year 2025. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,194
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Mallinckrodt Enterprises LLC, plan 501 (1,194 participants); Mallinckrodt Enterprises LLC Benefit Plans, plan 503 (100 participants)
Broker compensation
$296K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Life Insurance Company of North AmericaLife, Long-term disability711$3.1M$192K
Reliastar Life Insurance CompanyAccident, Critical Illness, Hospital1,384$342K$76K
Vision Service PlanVision1,822$218K—
Hartford Life and AccidentLife389$136K$3K
Transamerica Life Insurance CompanyLife135$82K$15K
MetLife Legal PlansLegal218$45K$5K
Federal Insurance CompanyBusiness Travel Accident711$20K$5K
Aetna Behavioral Health LLCEmployee Assistance Program711$18K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$2.8M/ year

Estimated prescription spend: 1,194 participants × $2,371 national average per member. Usually higher once dependents are counted.

$74K–$181K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$22K–$54K
Lower-cost therapeutic alternatives$31K–$66K
Generic pricing vs. actual cost$14K–$41K
PBM contract terms$7K–$21K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Mallinckrodt Enterprises LLC
Sponsor EIN
36-4679061
Plan numbers
501, 503
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 36-4679061 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Par Health Savings and Investment Plan
Type
401(k) plan
Participants
4,143

About this data

Source: Mallinckrodt Enterprises LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Mallinckrodt Enterprises LLC.

Request a correction · Methodology